US Stock MarketDetailed Quotes

IMRX Immuneering

Watchlist
  • 1.170
  • +0.020+1.74%
Trading Jul 25 09:55 ET
34.69MMarket Cap-629P/E (TTM)

Immuneering Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Immuneering Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.49

+3.92%
Analyst Rating

Strong Buy

Jul 25, 2024

Immuneering Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Immuneering Earnings Reports

  • Immuneering | 10-Q: Quarterly report

    May 7 16:11 ET

  • Immuneering | 10-K: Annual report

    Mar 1 08:09 ET

  • Immuneering: Q3 2023 Earnings Report

    Nov 9, 2023 16:12 ET

  • Immuneering | 10-Q: Q2 2023 Earnings Report

    Aug 3, 2023 16:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 25, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg